Generic Name and Formulations:
Lodoxamide tromethamine 0.1%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for ALOMIDE:
Vernal conjunctivitis, keratoconjunctivitis, or keratitis.
Adults and Children:
<2yrs: not recommended. ≥2yrs: 1–2 drops 4 times daily for up to 3 months.
Do not wear soft contact lenses during treatment.
Pregnancy (Cat.B). Nursing mothers.
Mast cell stabilizer.
Transient burning, stinging or discomfort, pruritus, blurred vision, dry eye, discharge, hyperemia, crystalline deposits, foreign body sensation, headache.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL